Need extra support quickly? We are working with clients around the world right now to help them tackle new challenges from COVID-19. How can we help you? Learn More >

ProPharma Group is the truly global, independent, single-source provider of regulatory, compliance, pharmacovigilance, and medical information services serving pharmaceutical, biotechnology, and medical device companies. Our team of experts brings a comprehensive portfolio of regulatory and compliance solutions to help solve complex challenges in a dynamic regulatory environment. With our mission to improve the health and safety of patients, we are focused on delivering the highest quality of services throughout the full product lifecycle.

Quote

We work in close partnership with our clients, often as an extension of their teams, to improve the health and safety of patients.  Our ability to be nimble, coupled with a passion for excellence ensures our services exceed clients’ expectations.

Dawn Sherman
Chief Executive Officer
Dawn Sherman
Chief Executive Officer

Fast Facts

395+ Bilingual Native Speakers

Our fully integrated Medical Information contact centers span 4 continents with a team of 395+ bilingual native speakers covering 30+ languages

Presence Across 6 Continents

Providing critical support services to global pharmaceutical, biotechnology, and medical device clients across 6 continents

1200+ Strong and Counting

From 15 offices in 8 countries, our growing team of 1200+ professionals provide the highest quality of services on a global scale supported by regional expertise

Company History

2019

Expand our support for clients throughout all phases of the product lifecycle with the acquisitions of The Weinberg Group, a leading provider of Regulatory Affairs based in the United States and Southwood Research, a pre-approval regulatory science services provider based in the United Kingdom.

2018

  • To best service clients as a single-source provider, Xendo, Sofus Regulatory Affairs, and SOLUTIONS in Health were integrated into the global ProPharma Group brand.
  • Acquired SOLUTIONS in Health, a Canada-based provider of Medical Information services.
  • Further Expanded our global support capabilities, with a new contact center in Fort Washington, PA.
  • Expanded our global reach and service offerings for compliance consulting, regulatory affairs, and pharmacovigilance with the acquisition of Xendo which included Sofus Regulatory.

2017

  • Expanded our Pharmacovigilance services with acquisition of Drug Safety Solutions, a clinical safety company.
  • Expanded global support with new contact center in Tokyo, Japan.

2015

Further expansion of services, ProPharma Group acquired the leading provider of Pharmacovigilance services, PROSAR.

2014

To further expand our Medical Information capabilities, ProPharma Group acquired Professional Information Ltd (PI) operating in the United Kingdom and Australia.

2011

We expanded our service offerings to include Medical Information through the acquisition of Advanced Response Management (ARM).

2007

ProPharma Group joined forces with Computer Compliance to deliver an enhanced experience in validation of automated systems, computers, and IT services.

2001

ProPharma Group was established to provide validation and related services in the pharmaceutical, biotechnology, and medical device industries.

Our Leadership Team

Dawn Sherman

Chief Executive Officer

Rob Chestnut

Chief Financial Officer

Jason DeGoes

Chief Operating Officer

Joe Donnici

Chief Information Officer

Hans Luijendijk

General Manager, Europe

Joe Biehl

General Manager, Americas & APAC

Eva Lindgren

General Manager, Sweden

Steve Swantek

Senior Vice President, Business Development

Rachel Bias

Senior Vice President, Human Resources

Dennis Schonbachler

Vice President, Strategic Initiatives & Market Intelligence

Thomas Chatzopoulos

Vice President, Global Pharmacovigilance

Kathleen Meyer Ritz

Vice President, Global Medical Information

Jim Kolbet

Vice President, US Consulting

Matthew Weinberg

Chief Executive Officer, The Weinberg Group, Vice President Global Regulatory Affairs

Dr. Colin Wheeler

Vice President, European Regulatory Affairs

Jean Marie Thompson

Vice President, Marketing

ProPharma Group Board

Anthony Davis

Michael Farah

Jeff Hargroves

Joshua Reilly

Dawn Sherman

Richard Thomas


Looking to Ensure Regulatory and Development Success Throughout the Lifespan of Your Product?

Contact us to learn more about how we can help you at every step of the product development lifecycle to improve patient health and safety.

Interested in gaining an industry edge? Let us help you stay current.


All fields are required.